. . "investigational"@en . . . . . . . . . . "# Bennett B, Matagne A, Michel P, Leonard M, Cornet M, Meeus MA, Toublanc N: Seletracetam (UCB 44212). Neurotherapeutics. 2007 Jan;4(1):117-22. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17199025 # Bialer M: New antiepileptic drugs that are second generation to existing antiepileptic drugs. Expert Opin Investig Drugs. 2006 Jun;15(6):637-47. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16732716"@en . . . "UCB 44212 is indicated for the treatment of various types seizure disorders such as epilepsy, a neurological dysfunction in which excessive surges of electrical energy are emitted in the brain, and other disorders."@en . . "UCB 44212"@en . . "Investigated for use/treatment in epilepsy."@en . . . . . . . . . . . . . . . . "UCB 44212 is effective in controlling the seizures associated with epilepsy. Some anticonvulsants are thought to generally depress central nervous system (CNS) function. Others, such as GABA inhibitors, are thought to target specific neurochemical processes, suppress excess neuron function, and regulate electrochemical signals in the brain."@en . .